Harold A Harvey

Harold A Harvey

UNVERIFIED PROFILE

Are you Harold A Harvey?   Register this Author

Register author
Harold A Harvey

Harold A Harvey

Publications by authors named "Harold A Harvey"

Are you Harold A Harvey?   Register this Author

19Publications

508Reads

47Profile Views

Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.

Drug Resist Updat 2017 05 19;32:1-15. Epub 2017 Aug 19.

Department of Pharmacology, The Penn State Cancer Institute, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S13687646173003
Publisher Site
http://dx.doi.org/10.1016/j.drup.2017.07.002DOI Listing
May 2017

Primary female breast sarcoma: clinicopathological features, treatment and prognosis.

Sci Rep 2016 08 11;6:31497. Epub 2016 Aug 11.

Division of Hematology and Oncology, Penn State Hershey Cancer Institute, Hershey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep31497DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980597PMC
August 2016

Endoscopic ultrasound-guided ethanol ablation of a large metastatic carcinoid tumor: success with a note of caution.

Endosc Int Open 2014 Dec 19;2(4):E256-8. Epub 2014 Sep 19.

Penn State Hershey Medical Center - Gastroenterology and Hepatology, Hershey, Pennsylvania, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0034-1377612DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423311PMC
December 2014

Predicting therapy response in live tumor cells isolated with the flexible micro spring array device.

Cell Cycle 2013 Jul 11;12(13):2132-43. Epub 2013 Jun 11.

Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Division of Hematology-Oncology, Penn State Hershey Cancer Institute; Hershey, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.25165DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3737315PMC
July 2013

Update on clinical trials: genetic targets in breast cancer.

Adv Exp Med Biol 2013 ;779:35-54

Penn State University Milton S. Hershey Medical Center, Hershey, PA 17033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4614-6176-0_2DOI Listing
April 2013

Gastrointestinal stromal tumor (GIST) recurrence following surgery: review of the clinical utility of imatinib treatment.

Ther Clin Risk Manag 2010 Oct 5;6:453-8. Epub 2010 Oct 5.

Program for Liver, Pancreas and Foregut Tumors, Department of Surgery, Penn State College of Medicine, Hershey, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/TCRM.S5634DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952484PMC
October 2010

Biology of bone metastases: causes and consequences.

Clin Breast Cancer 2007 Jul;7 Suppl 1:S7-S13

Milton S. Hershey Medical Center, Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/cbc.2007.s.001DOI Listing
July 2007

Toremifene: an evaluation of its safety profile.

Breast 2006 Apr 9;15(2):142-57. Epub 2005 Nov 9.

Division of Hematology/Oncology, Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA 17033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2005.09.007DOI Listing
April 2006

Hypercalcemia and gallium nitrate.

J Support Oncol 2004 Nov-Dec;2(6):516-7

View Article

Download full-text PDF

Source
January 2006

Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy.

Cancer 2005 Jul;104(2):257-63

Department of Hematology/Oncology, Hershey Medical Center, Penn State University, Hershey, Pennsylvania 17033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21202DOI Listing
July 2005

Optimizing bisphosphonate therapy in patients with breast cancer on endocrine therapy.

Authors:
Harold A Harvey

Semin Oncol 2004 Dec;31(6 Suppl 12):23-30

Penn State Milton S. Hershey Medical Center, Hershey, PA 17033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2004.09.023DOI Listing
December 2004

Treatment of advanced pancreatic cancer with opioid growth factor: phase I.

Anticancer Drugs 2004 Mar;15(3):203-9

Department of Medicine, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00001813-200403000-00003DOI Listing
March 2004

Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer.

J Clin Oncol 2002 Mar;20(6):1467-72

Department of Hematology and Oncology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2002.20.6.1467DOI Listing
March 2002